Pharming Group N.V.
Status: Publicly traded
Direct answer
Pharming Group N.V. is publicly traded on NASDAQ under the ticker PHAR.
Pharming Group N.V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets. Its primary commercialized product is Ruconest, a recombinant human C1 esterase inhibitor utilized...
Can you invest in Pharming Group N.V.?
Yes. Pharming Group N.V. trades publicly on NASDAQ as PHAR.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Pharming Group N.V.
Detailed equity research is provided by MarketSnap.